US Bancorp’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.3K | Buy |
3,933
+2,009
| +104% | +$22.6K | ﹤0.01% | 2832 |
|
|
2025
Q1 | $19.4K | Sell |
1,924
-812
| -30% | -$8.19K | ﹤0.01% | 3176 |
|
|
2024
Q4 | $32.4K | Sell |
2,736
-542
| -17% | -$6.41K | ﹤0.01% | 2944 |
|
|
2024
Q3 | $37.8K | Buy |
3,278
+1,948
| +146% | +$22.5K | ﹤0.01% | 2868 |
|
|
2024
Q2 | $14.1K | Buy |
1,330
+15
| +1% | +$159 | ﹤0.01% | 3179 |
|
|
2024
Q1 | $13.9K | Sell |
1,315
-118
| -8% | -$1.24K | ﹤0.01% | 3216 |
|
|
2023
Q4 | $16.1K | Sell |
1,433
-433
| -23% | -$4.86K | ﹤0.01% | 3136 |
|
|
2023
Q3 | $21.8K | Buy |
+1,866
| New | +$21.8K | ﹤0.01% | 2835 |
|
|
2023
Q2 | – | Sell |
-79
| Closed | -$583 | – | 4063 |
|
|
2023
Q1 | $583 | Hold |
79
| – | – | ﹤0.01% | 3912 |
|
|
2022
Q4 | $631 | Buy |
+79
| New | +$631 | ﹤0.01% | 3954 |
|